本文へスキップ

相互作用

Avapritinib + Netupitant-palonosetron

重症度: 重大

Avapritinib and Netupitant-palonosetron: major interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Netupitant is a moderate CYP3A4 inhibitor and can increase avapritinib concentrations. This raises the risk of avapritinib toxicity such as cognitive effects, intracranial hemorrhage and edema.

この相互作用をわかりやすく説明すると

Avapritinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Avapritinib belongs to Oncology; Netupitant-palonosetron belongs to Gastrointestinal Tract.

エビデンスレベル: Moderate

なぜ起こるのか

Inhibition of CYP3A4-mediated avapritinib metabolism by netupitant.

対処法

Avoid the combination; use an antiemetic regimen without CYP3A4 inhibition. If unavoidable, follow avapritinib labeling for dose reduction with CYP3A inhibitors and monitor for adverse effects.

薬剤師に尋ねること

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、AvapritinibとNetupitant-palonosetronの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Avapritinib with Netupitant-palonosetron?

MediHelp rates the interaction as major. Avapritinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Netupitant is a moderate CYP3A4 inhibitor and can increase avapritinib concentrations. This raises the risk of avapritinib toxicity such as cognitive effects, intracranial hemorrhage and edema.

How serious is the interaction between Avapritinib and Netupitant-palonosetron?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; use an antiemetic regimen without CYP3A4 inhibition. If unavoidable, follow avapritinib labeling for dose reduction with CYP3A inhibitors and monitor for adverse effects.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン